ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,305Medicare Part D Prescriptions Filled, Including Refills

Rank: 232 out of 2343

$770K Total Retail Price of All Prescriptions

Rank: 263 out of 2343

637 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 637 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

5% of this provider’s 637 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 13,435 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
AMLODIPINE BESYLATE 705 686 1 5
LISINOPRIL 683 672 2 3
SIMVASTATIN 654 591 3 1
METOPROLOL TARTRATE 645 632 4 7
LEVOTHYROXINE SODIUM 540 491 5 2
ATORVASTATIN CALCIUM 466 437 6 10
OMEPRAZOLE 441 396 7 4
FUROSEMIDE 377 366 8 6
WARFARIN SODIUM 371 371 9 8
HYDROCHLOROTHIAZIDE 330 330 10 11
CITALOPRAM HBR 313 302 11 17
METOPROLOL SUCCINATE 303 303 12 14
ATENOLOL 242 230 13 12
ZOLPIDEM TARTRATE 238 237 14 24
LOSARTAN POTASSIUM 229 209 15 19
METFORMIN HCL 207 176 16 9
GLIMEPIRIDE 182 180 17 45
ALENDRONATE SODIUM 173 173 18 28
FAMOTIDINE 168 168 19 60
GABAPENTIN 146 135 20 16
PRAVASTATIN SODIUM 140 127 21 15
PANTOPRAZOLE SODIUM 136 118 22 22
CRESTOR 136 136 22 30
DIOVAN 132 130 24 23
DIGOXIN 130 127 25 35
ALLOPURINOL 127 127 26 31
LIPITOR 121 118 27 78
SYNTHROID 117 114 28 40
HYDROCODONE-ACETAMINOPHEN 104 100 S3 29 13
METFORMIN HCL ER 103 83 30 88
TRAMADOL HCL 98 86 31 25
POTASSIUM CHLORIDE 97 97 32 18
PAROXETINE HCL 96 96 33 66
AZITHROMYCIN 88 78 34 39
TORSEMIDE 86 74 35 157
DOXAZOSIN MESYLATE 83 83 36 98
ISOSORBIDE MONONITRATE ER 81 81 37 32
DONEPEZIL HCL 81 81 37 21
ZETIA 78 72 39 52
SPIRIVA 78 78 39 48
MIRTAZAPINE 75 75 41 41
LISINOPRIL-HYDROCHLOROTHIAZIDE 74 71 42 42
TRIAMTERENE-HCTZ 72 70 43 57
CLOPIDOGREL 71 68 44 26
ACTOS 71 71 44 125
FLUTICASONE PROPIONATE 71 71 44 46
AMLODIPINE BESYLATE-BENAZEPRIL 70 70 47 59
PEN NEEDLE 69 52 48 119
RAMIPRIL 67 67 49 90
JANTOVEN 62 62 50 81
PREDNISONE 61 60 51 37
ADVAIR DISKUS 60 60 52 34
RANITIDINE HCL 60 60 52 43
BENAZEPRIL HCL 59 59 54 113
PLAVIX 56 54 55 38
TAMSULOSIN HCL 56 55 55 29
CLONIDINE HCL 55 55 57 70
KLOR-CON M10 52 52 58 107
TRAMADOL HCL-ACETAMINOPHEN 52 39 58 199
BISOPROLOL-HYDROCHLOROTHIAZIDE 51 41 60 151
VERAPAMIL ER 50 50 61 95
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 29, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.